Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:DiVA.org:uu-339521" > Tumoral ANXA1 Is a ...

1 of 1
Previous record
Next record
To hitlist

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Niinivirta, Marjut (author): Uppsala universitet,Experimentell och klinisk onkologi,Uppsala University Hospital, Department of Oncology

Enblad, Gunilla (author): Uppsala universitet,Experimentell och klinisk onkologi,Uppsala University Hospital, Department of Oncology

Edqvist, Per-Henrik D (author): Uppsala universitet,Science for Life Laboratory, SciLifeLab,Experimentell och klinisk onkologi

Pontén, Fredrik (author): Uppsala universitet,Klinisk och experimentell patologi,Science for Life Laboratory, SciLifeLab,Fredrik Pontén

Dragomir, Anca (author): Uppsala universitet,Klinisk och experimentell patologi,Science for Life Laboratory, SciLifeLab,Fredrik Pontén

Ullenhag, Gustav (author): Uppsala universitet,Experimentell och klinisk onkologi,Uppsala University Hospital, Department of Oncology

show less...

(creator_code:org_t)

Ivyspring International Publisher, 2017
2017
English.
In: Journal of Cancer. - : Ivyspring International Publisher. - 1837-9664. ; 8:19, s. 3975-3983

Related links:: https://doi.org/10.7...; show more...; https://uu.diva-port... (primary) (Raw object); https://www.jcancer....; https://urn.kb.se/re...; https://doi.org/10.7...; show less...

Journal article (peer-reviewed)

Abstract Subject headings

Background and aims: There is no established predictive marker for the treatment of renal cancer. Metastatic renal cell carcinoma (mRCC) patients are often treated with sunitinib, a tyrosine kinase inhibitor. Sunitinibs anti-cancer effect is at least partly mediated through interfering with angiogenesis. Our aim with the current study was to assess annexin A1 (ANXA1), which stimulates angiogenesis, as a predictive marker for sunitinib therapy in mRCC patients. Since previous studies have indicated a predictive potential for cubilin, we also investigated the predictivity of ANXA1 combined with cubilin.Methods: ANXA1 expression was analysed in tumor tissue from a cohort of patients with advanced RCC (n= 139) using immunohistochemistry. Ninety-nine of the patients were treated with sunitinib in the first or second-line setting. Twenty-two of these were censored because of toxicity leading to the termination of treatment and the remaining (n= 77) were selected for the present study.Results: Twenty-five (32%) out of seventy-seven of the tumors lacked ANXA1 in the cytoplasm. On statistical analyses using Kaplan-Meier method, aNXA1 negative tumors were significantly associated with a longer treatment benefit in terms of progression free survival (PFS). Overall survival was also significantly better for patients with ANXA1 negative tumors. The combined ANXA1 positive and cubilin negative expression could more accurately than ANXA1 alone define the group not benefitting from treatment.Conclusions: Our results indicate that cytoplasmic expression of ANXA1 is a negative predictive marker for sunitinib therapy in mRCC patients. A possible explanation for this finding is that sunitinibs anti-angiogenic effect cannot overcome the pro-angiogenic drive from many ANXA1 proteins.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)

Keyword

Renal cancer
sunitinib
tissue microarray
predictive marker
ANXA1
Patologi
Pathology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

Journal of Cancer (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Niinivirta, Marj ...; Enblad, Gunilla; Edqvist, Per-Hen ...; Pontén, Fredrik; Dragomir, Anca; Ullenhag, Gustav

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Clinical Laborat ...

Articles in the publication: Journal of Cance ...

By the university: Uppsala University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se